Stay updated with breaking news from Nasdaq Prds. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pardes Biosciences, Inc. (NASDAQ:PRDS – Get Rating) – Research analysts at Jefferies Financial Group decreased their Q2 2023 EPS estimates for Pardes Biosciences in a research report issued on Monday, April 3rd. Jefferies Financial Group analyst D. Ding now expects that the company will earn ($0.36) per share for the quarter, down from their previous […]
Pardes Biosciences (NASDAQ:PRDS – Get Rating) was downgraded by stock analysts at SVB Securities from an “outperform” rating to a “market perform” rating in a report released on Tuesday, The Fly reports. Several other brokerages also recently commented on PRDS. JMP Securities reduced their target price on Pardes Biosciences from $9.00 to $5.00 and set […]
Pardes Biosciences, Inc. (NASDAQ:PRDS – Get Rating) – Investment analysts at SVB Leerink decreased their Q1 2023 earnings per share estimates for Pardes Biosciences in a report issued on Monday, April 3rd. SVB Leerink analyst R. Ruiz now forecasts that the company will earn ($0.38) per share for the quarter, down from their previous estimate […]
Pardes Biosciences (NASDAQ:PRDS – Get Rating) was downgraded by stock analysts at Jefferies Financial Group from a “buy” rating to a “hold” rating in a research note issued on Monday, The Fly reports. Several other equities research analysts have also recently commented on the stock. JMP Securities cut their price target on shares of Pardes […]
TD Asset Management Inc. trimmed its holdings in Pardes Biosciences, Inc. (NASDAQ:PRDS – Get Rating) by 36.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 26,500 shares of the company’s stock after selling 15,105 shares during the period. TD Asset Management […]